Author:
Peeters Pierre A. M.,van den Heuvel Michiel W.,Heumen Emiel van,Passier Paul C. C. M.,Smeets Jean M. W.,van Iersel Thijs,Zwiers Alex
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference21 articles.
1. Murphy GS. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period. Minerva Anestesiol 2006 Mar; 72(3): 97–109
2. EMA. European Public Assessment Report (EPAR). Bridion. EPAR summary for the public, updated June 2010 [online]. Available from URL:
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000885/WC500052310.pdf
[Accessed 2010 Jul 19]
3. Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002 Jan; 41(2): 266–70
4. Epemolu O, Bom A, Hope F, et al. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969. Anesthesiology 2003 Sept; 99(3): 632–7
5. deBoer HD, vanEgmond J, van de Pol F, et al. Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized rhesus monkeys. Anesthesiology 2006 Apr; 104(4): 718–23
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献